Algeria Boosts Health Sovereignty: Frater-Razes and Sanofi Partner for Local Insulin Production
Translated from French, summarized and contextualized by DistantNews.
TLDR
- Laboratoires Frater-Razes and Sanofi Algérie partner to produce advanced insulins locally.
- The initiative aims to strengthen Algeria's health sovereignty amid rising diabetes rates.
- This collaboration involves technology transfer and aims to reduce import dependency while boosting local pharmaceutical capabilities.
This strategic partnership between Laboratoires Frater-Razes and Sanofi Algérie marks a significant stride for Algeria's pharmaceutical industry and national health security. By committing to the local production of last-generation insulins, we are not just manufacturing a vital medication; we are asserting our nation's capacity for innovation and self-sufficiency.
The increasing prevalence of diabetes in Algeria, affecting over 4 million citizens, underscores the urgency of this initiative. Ensuring sustainable, secure, and equitable access to cutting-edge treatments is paramount. This collaboration directly addresses that need, leveraging advanced technology transfer from Sanofi to produce insulin that meets the highest international standards, right here at home.
L’Algérie n’attend plus : elle innove, elle produit et elle soigne avec ses propres moyens
This venture aligns perfectly with our national health authorities' directives and embodies a long-term vision to diminish our reliance on imports. It is a testament to the strength of Algerian industry, powered by highly qualified local talent operating in facilities compliant with Good Manufacturing Practices. As Dr. Abdelhamid Cherfaoui, CEO of Laboratoires Frater-Razes, aptly stated, 'Algeria no longer waits: it innovates, it produces, and it heals with its own means.' This is the spirit driving our progress.
Beyond insulin, this partnership lays the groundwork for a robust biopharmaceutical ecosystem. It fosters skilled job creation and develops local expertise, extending the potential for producing other strategic medicines. This alliance fortifies our healthcare system's resilience, ensuring better preparedness for future supply chain challenges and continuity of care. It is a proud moment for Algerian industry and public health.
un levier structurant pour améliorer l’accès aux traitements et en garantir la disponibilité dans la durée
DistantNews Editorial
Originally published by El Watan in French. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.
More Stories
From Our Blog
What Gets Lost (and Found) When News Is Translated
The Critical Role of Diaspora Media in Global News
What Travellers Should Know About Countries with Restricted Press
A Digital Nomad's Guide to Following Local News
How the Same Story Looks Different in Different Countries
